Amodiaquine and Covid-19

  • Amodiaquine and Covid-19

     Adam updated 9 months ago 0 Member · 1 Post
  • Adam

    April 30, 2021 at 6:38 pm

    Can someone update me on whats happened to the Amodiaquine research

    Amodiaquine was first made in 1948.[6]It is on the World Health Organization’s List of Essential Medicines, the safest and most effective medicines needed in a health system.

    Amodiaquine Covid-19 research was funded by military …

    in April [2020], tenOever’s funders at the US Defense Advanced Research Projects Agency asked him to run the tests. “I was really reluctant to do it,” he says, “but we did eventually come to try.”

    The first time tenOever and his collaborators gave the drug to hamsters in his lab, in early June, it offered considerable protection against the virus that causes Covid-19. “We thought, ‘Oh, OK, that was weird. Let’s do it again,’” tenOever says. They kept repeating it and seeing good results. The research team, which includes Donald Ingber of the Wyss Institute in Boston, had already shown that, in human lung cells, the drug reduces levels of a harmless virus engineered to carry the same spike protein as the pandemic one. “It works beautifully,” tenOever says.

    Benjamin tenOever, a microbiologist at the Icahn School of Medicine at Mount Sinai in New York and one of the authors of the new study, describes amodiaquine as being “dirtier” than its cousins. That means that its effects on cells are more spread out, hitting a greater variety of molecular targets. As biochemist Bryan Roth once told Nature, a dirty drug may be less like a “magic bullet” than a “magic shotgun.”

Viewing 1 of 1 replies

Start of Discussion
0 of 0 posts June 2018